Search

Phung M. Chung

Examiner (ID: 5808)

Most Active Art Unit
2117
Art Unit(s)
2111, 2785, 2117, 2784, 2413, 2133, 2138, 2306, 2313
Total Applications
1956
Issued Applications
1779
Pending Applications
38
Abandoned Applications
145

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20288766 [patent_doc_number] => 20250314009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => ODOR CONTROL COMPOSITION CONCENTRATES [patent_app_type] => utility [patent_app_number] => 19/178329 [patent_app_country] => US [patent_app_date] => 2025-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19178329 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/178329
ODOR CONTROL COMPOSITION CONCENTRATES Apr 13, 2025 Pending
Array ( [id] => 20163838 [patent_doc_number] => 20250255884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS [patent_app_type] => utility [patent_app_number] => 19/172483 [patent_app_country] => US [patent_app_date] => 2025-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19172483 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/172483
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis Apr 6, 2025 Issued
Array ( [id] => 20067067 [patent_doc_number] => 20250205289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN [patent_app_type] => utility [patent_app_number] => 19/075217 [patent_app_country] => US [patent_app_date] => 2025-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19075217 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/075217
Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between Mar 9, 2025 Issued
Array ( [id] => 20341757 [patent_doc_number] => 12465472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Methods of insect control for an animal, products thereof and methods for their preparation [patent_app_type] => utility [patent_app_number] => 18/900544 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 13720 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900544 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/900544
Methods of insect control for an animal, products thereof and methods for their preparation Sep 26, 2024 Issued
Array ( [id] => 19808401 [patent_doc_number] => 12239760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-03-04 [patent_title] => Antibacterial conductive self-healing hydrogel [patent_app_type] => utility [patent_app_number] => 18/898561 [patent_app_country] => US [patent_app_date] => 2024-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 60 [patent_no_of_words] => 13080 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18898561 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/898561
Antibacterial conductive self-healing hydrogel Sep 25, 2024 Issued
Array ( [id] => 19496476 [patent_doc_number] => 20240335494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/745158 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745158 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745158
TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS Jun 16, 2024 Pending
Array ( [id] => 19691120 [patent_doc_number] => 20250009665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => GASTRO-RESISTANT CONTROLLED RELEASE ORAL DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/738782 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738782 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/738782
GASTRO-RESISTANT CONTROLLED RELEASE ORAL DOSAGE FORMS Jun 9, 2024 Pending
Array ( [id] => 19477553 [patent_doc_number] => 20240325595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => Alginate Based Particles as a Temporary Embolic Agent [patent_app_type] => utility [patent_app_number] => 18/738275 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738275 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/738275
Alginate Based Particles as a Temporary Embolic Agent Jun 9, 2024 Pending
Array ( [id] => 20644623 [patent_doc_number] => 12599548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-14 [patent_title] => Method of treating oxidative stress in skin and compositions therefor [patent_app_type] => utility [patent_app_number] => 18/732895 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3357 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732895 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/732895
Method of treating oxidative stress in skin and compositions therefor Jun 3, 2024 Issued
Array ( [id] => 19446561 [patent_doc_number] => 20240306691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => Personalized Nutritional Supplements and Methods of Making [patent_app_type] => utility [patent_app_number] => 18/671721 [patent_app_country] => US [patent_app_date] => 2024-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18671721 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/671721
Personalized Nutritional Supplements and Methods of Making May 21, 2024 Pending
Array ( [id] => 19447171 [patent_doc_number] => 20240307301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => CHEWABLE PHARMACEUTICAL PRODUCT FOR DELIVERY OF COLESEVELAM HYDROCHLORIDE [patent_app_type] => utility [patent_app_number] => 18/668674 [patent_app_country] => US [patent_app_date] => 2024-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18668674 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/668674
CHEWABLE PHARMACEUTICAL PRODUCT FOR DELIVERY OF COLESEVELAM HYDROCHLORIDE May 19, 2024 Abandoned
18/708130 CALCIFEROLS TO REDUCE ENVIRONMENTAL IMPACT OF RODENTICIDES May 6, 2024 Pending
Array ( [id] => 19982697 [patent_doc_number] => 20250120919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => COMPOSITIONS OF MIDODRINE AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/656110 [patent_app_country] => US [patent_app_date] => 2024-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18656110 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/656110
COMPOSITIONS OF MIDODRINE AND METHODS OF USING THE SAME May 5, 2024 Pending
Array ( [id] => 19784132 [patent_doc_number] => 20250057811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => FORMULATIONS OF AG10 [patent_app_type] => utility [patent_app_number] => 18/650542 [patent_app_country] => US [patent_app_date] => 2024-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18650542 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/650542
Formulations of AG10 Apr 29, 2024 Issued
Array ( [id] => 19417386 [patent_doc_number] => 20240293509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => METHODS OF TREATING INFLAMMATORY BOWEL DISEASE [patent_app_type] => utility [patent_app_number] => 18/640662 [patent_app_country] => US [patent_app_date] => 2024-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640662 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/640662
METHODS OF TREATING INFLAMMATORY BOWEL DISEASE Apr 18, 2024 Pending
Array ( [id] => 19768287 [patent_doc_number] => 20250049713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => LIPID NANOPARTICLES FOR DELIVERY OF AGENTS [patent_app_type] => utility [patent_app_number] => 18/634595 [patent_app_country] => US [patent_app_date] => 2024-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634595 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/634595
LIPID NANOPARTICLES FOR DELIVERY OF AGENTS Apr 11, 2024 Pending
Array ( [id] => 20644685 [patent_doc_number] => 12599610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-14 [patent_title] => Solid dosage formulations of an orexin receptor antagonist [patent_app_type] => utility [patent_app_number] => 18/630275 [patent_app_country] => US [patent_app_date] => 2024-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8869 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630275 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/630275
Solid dosage formulations of an orexin receptor antagonist Apr 8, 2024 Issued
Array ( [id] => 19496363 [patent_doc_number] => 20240335381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => Transdermal Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones [patent_app_type] => utility [patent_app_number] => 18/629522 [patent_app_country] => US [patent_app_date] => 2024-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -62 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629522 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/629522
Transdermal Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones Apr 7, 2024 Pending
Array ( [id] => 19379182 [patent_doc_number] => 20240269052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => Sulfate-Free Personal Care Compositions and Methods for Preventing and Treating Pollution Damage to Skin [patent_app_type] => utility [patent_app_number] => 18/623605 [patent_app_country] => US [patent_app_date] => 2024-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18623605 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/623605
Sulfate-Free Personal Care Compositions and Methods for Preventing and Treating Pollution Damage to Skin Mar 31, 2024 Pending
Array ( [id] => 20254781 [patent_doc_number] => 12427114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Orodispersible dosage unit containing an estetrol component [patent_app_type] => utility [patent_app_number] => 18/621501 [patent_app_country] => US [patent_app_date] => 2024-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3736 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621501 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/621501
Orodispersible dosage unit containing an estetrol component Mar 28, 2024 Issued
Menu